Clinical Trials Directory

Trials / Completed

CompletedNCT04187079

Immunopathologic Profiles and Blood Biomarkers in Patients With IPF

Immunopathologic Profiles of the Lung Micro- Environment Using Cryobiopsies and Identification of Blood Biomarkers in Patients With IPF

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
University of Aarhus · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Examination of expression of PD-L1, PD-L2, Beta- catenin, B-cell follicles and Tenascin- C in patients with IPF compared with other interstitial lung diseases. Examination of anti HSP 70, p-ANCA, c-ANCA, CD4+/CD28- and CD8+/CD28- cells in patients with IPF compared with other interstitial lung diseases. Compare the above mentioned findings with changes in pulmonary function tests, 6 minute walking test, exacerbation and mortality over a 2 year follow-up period.

Detailed description

Examination of expression of PD-L1, PD-L2, Beta- catenin, B-cell follicles and Tenascin- C in cryobiopsies from the lungs inpatients with IPF compared with other interstitial lung diseases. Examination of anti HSP 70, p-ANCA, c-ANCA, CD4+/CD28- and CD8+/CD28- cells in blood samples in patients with IPF compared with other interstitial lung diseases. Compare the above mentioned findings with changes in pulmonary function tests, 6 minute walking test, exacerbation and mortality over a 2 year follow-up period.

Conditions

Timeline

Start date
2017-09-18
Primary completion
2019-05-01
Completion
2021-07-27
First posted
2019-12-05
Last updated
2021-08-10

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT04187079. Inclusion in this directory is not an endorsement.